Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
     
  2. Our Websites |
     
  3. Global Business Websites |
     
  4. Contact Us |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce Increase  
 
 

About us

Contact Us

sanofi-aventis (Malaysia) Sdn. Bhd. (334110-P)

Unit TB-18-1, Level 18
Tower B, Plaza 33
No.1 Jalan Kemajuan, Seksyen 13
46200 Petaling Jaya
Selangor

Tel : +603 7651 0800
Fax: +603 7651 0801/2

Content :

Our Company

A diversified global healthcare leader, focused on patients’ needs.

 

Sanofi-aventis is one of the world’s leading pharmaceutical companies.

The Group operates in more than 100 countries, with around 100,000 employees. It has approximately 17,600 scientists working in over 28 research centers in three continents to create innovative therapeutic treatments.

Our global headquarters are in Paris, France.

7 major therapeutic areas

We have leading products across a range of therapeutic areas and we are committed to research and innovation to meet the current and future medical needs. Sanofi-aventis focuses its activities on 7 major therapeutic areas:

Great medicines for millions of patients

The sanofi-aventis portfolio of marketed products includes several medicines that are world leaders in their respective classes, in the areas of thrombosis, cardiovascular disease, bone disease, sleep disorders, epilepsy, diabetes and cancer.

A highly productive and innovative Research & Development organisation

With more than 25 research centres on three continents, sanofi-aventis coordinates its Research and Development on a worldwide basis.  The sanofi-aventis annual R&D budget exceeds four billion euros and ranks among the three largest budgets of global pharmaceutical industry. Sanofi-aventis currently possesses one of the richest and most innovative portfolios in the industry with more than 100 molecules and vaccines in development, half of which are in advanced stages (phases II and III).

The mission of sanofi-aventis research: to find truly innovative drugs that provide new therapeutic solutions to patients.

For more information about sanofi-aventis worldwide, visit www.sanofi-aventis.com.

Module :

Corporate information

Corporate information

 

News

November 03, 2014

The New England Journal of Medicine Publishes Results of Final Landmark Phase III Efficacy Clinical Study of Sanofi Pasteur’s Dengue Vaccine Candidate